Pharmaceutical companies spend more on research and development
initiatives than on all drug promotional activities, including DTC
advertising. According to industry estimates, pharmaceutical companies
spent $30.3 billion on research and development and $19.1 billion on all
promotional activities, which includes $2.7 billion on DTC advertising, in
2001. Pharmaceutical companies have increased spending on DTC
advertising more rapidly than they have increased spending on research
and development. Between 1997 and 2001, DTC advertising spending
increased 145 percent, while research and development spending
increased 59 percent. Promotion to physicians accounted for more than 80
percent of all promotional spending by pharmaceutical companies in 2001.
Total promotional spending was equivalent to 12 percent of drug sales in
the United States in 2001.